Key Developments: Amyris Inc (AMRS.O)
2.81USD
24 May 2013
$-0.04 (-1.40%)
$2.85
$2.81
$2.84
$2.78
105,797
279,187
$4.56
$2.16
Latest Key Developments (Source: Significant Developments)
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Amyris Inc .
Bernstein Liebhard LLP announced that a class action has been commenced in the United States District Court for the Northern District of California on behalf of a class (the Class) of purchasers of Amyris Inc securities between April 29, 2011 and February 8, 2012, inclusive (the Class Period). Full Article
Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Amyris Inc
Bronstein, Gewirtz & Grossman, LLC announced that a class action law suit was filed in the United States District Court for the Northern District of California on behalf of purchasers of Amyris Inc stock between April 29, 2011 and February 8, 2012 inclusive (the "Class Period"). Full Article
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Amyris Inc
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of a class comprising all purchasers of the securities of Amyris, Inc. (Amyris or the Company) between November April 29, 2011 and February 8, 2012, inclusive. Full Article
Amyris Inc Selects Laserson as Squalane Distributor in Europe
Amyris Inc announced the selection of Laserson, S.A., a supplier of ingredients for the health and beauty industries, as the new exclusive distributor of Amyris Squalane in the European market. The joint announcement was made in Paris at In-Cosmetics, the trade show for the personal care ingredients industry. Full Article
Amyris Inc Secures Additional Financing
Amyris Inc announced that it has completed a $42.25 million private placement of its common stock. The Company sold 14,177,849 shares of common stock in a private placement to existing Amyris investors. The transaction included $37.25 million in cash proceeds and the conversion by Total Gas & Power USA, SAS of $5 million from an outstanding senior unsecured convertible promissory note. Full Article
The Law Firm of Wohl & Fruchter LLP Announces Investigation Of Amyris Inc
The law firm of Wohl & Fruchter LLP announced that it has commenced an investigation concerning possible violations of federal securities laws by officers and Directors of Amyris, Inc. Wohl & Fruchter’s investigation concerns whether the Company’s statements regarding ability to produce Biofene in commercial quantities in mid-2011 accurately reflected internal information available to management. Full Article
Amyris Inc Receives $8 Million DARPA Contract Under Living Foundries Program
Amyris Inc announced that it has been awarded a contract from the U.S. Department of Defense Advanced Research Projects Agency (DARPA) to develop tools that can expand the scope of Amyris's industrial synthetic biology technology platform across various biological platforms and cell types. The contract is worth approximately $8 million in funds to Amyris, conditioned on meeting certain technical milestones in connection with the DARPA's Living Foundries research program. Full Article
Amyris, Inc. Names Steven R. Mills As New Chief Financial Officer
Amyris, Inc. announced that Steven R. Mills has been appointed Chief Financial Officer(CFO) effective May 2, 2012. Mills will replace Jeryl L. Hilleman, whose intent to depart during the course of this year was first announced in August 2011. Full Article
Amyris, Inc. Secures $83.7 Million In Additional Financing
Amyris, Inc. announced that it has completed a $58.7 million private placement of its common stock and entered into a definitive agreement to privately place $25 million in aggregate principal amount of 3% senior unsecured notes due 2017. The placement of notes is expected to be completed by February 28, 2012. The private placement of its common stock included existing Amyris investors Temasek Holdings, Total Gas & Power USA, SAS, and Naxyris SA (an affiliate of NAXOS Capital Partners), as well as new investors Biolding Investment SA (a company owned by HH Sheikh Abdullah bin Khalifa Al-Thani of Qatar), an entity affiliated with director John Doerr (of Kleiner Perkins Caufield & Byers, a current stockholder), and an entity affiliated with director Fernando Reinach. Full Article
Total SA And Amyris, Inc. Partners To Produce Renewable Fuels
Total SA and Amyris, Inc. announced the signing of agreements to expand their current R&D partnership and form a joint venture to develop, produce and commercialize a range of renewable fuels and products. Total and Amyris have agreed to expand their ongoing research and development collaboration to accelerate the deployment of Biofene and develop renewable diesel based on this molecule produced from plant sugars. Total has committed to contribute $105 million in funding for an existing $180 million program. In addition, Total and Amyris have agreed to form a 50-50 joint venture company that will have exclusive rights to produce and market renewable diesel and jet fuel worldwide, as well as non-exclusive rights to other renewable products such as drilling fluids, solvents, polymers and specific biolubricants. The venture aims to begin operations in the first quarter of 2012. Full Article
BRIEF-Amyris shares up 15.3 percent in premarket trading
NEW YORK, April 11 - Amyris Inc : * Shares up 15.3 percent in premarket trading
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
